Recurrent Uveal Melanoma
6 clinical trials · Condition
◉ Watch Recurrent Uveal Melanoma
| Record | Firm | Date |
|---|---|---|
| Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma (NCT02363283) | National Cancer Institute (NCI) | 2015-09-16 |
| Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma (NCT01961115) | Fred Hutchinson Cancer Center | 2013-09-13 |
| Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery (NCT01835145) | National Cancer Institute (NCI) | 2013-07-31 |
| Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye (NCT01143402) | National Cancer Institute (NCI) | 2010-06-01 |
| Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery (NCT01989572) | National Cancer Institute (NCI) | 2000-02-23 |
Track Recurrent Uveal Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.